Lannett wins FDA approval for generic Actigall (Pharmaceutical Business Review)
Lannett Company, a manufacturer of generic pharmaceuticals, has received the FDA approval of its abbreviated new drug application for Ursodiol 300mg capsules, the generic equivalent of Actigall marketed by Watson Pharmaceuticals.

Neuralstem Files FDA Application for First ALS Stem Cell Trial (ITNews)
ROCKVILLE, Maryland, December 19 /PRNewswire/ -- Neuralstem, Inc. (NYSE Alternext US: CUR) announced this morning that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a clinical trial to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).